Department of Pharmacy Practice, Srinivas College Of Pharmacy, Manglore-574143
The aim of this study was to assess the commonly occurring infection and commonly prescribed antibiotics in patients with renal impairment. This abstract aims to underscore the importance of tailored antibiotic management in renal patients, considering the unique challenges posed by impaired renal function. Strategies for infection prevention, early detection, and appropriate antibiotic stewardship are crucial elements in safeguarding renal health while effectively addressing infectious threats. Through a comprehensive exploration of infections and antibiotics in renal patients, this abstract seeks to contribute to a deeper understanding of the nuances involved in managing infectious complications in this vulnerable population. A retrospective study was conducted by screening the medical records of 100 patients who fulfilled the inclusion criteria. Most commonly occurring infections, antibiotic utilization was analysed using Microsoft Excel. The mean age of the study participant 59.8 years with 67% male and 33?male. Majority of the patients were diagnosed with CKD (56%). Most commonly occurring infections were found to be Sepsis (29.09%), RTI (29.09%), UTI (23.63%). Commonly utilized antibiotics were Inj.meropenem (21.42%), Inj. Ceftriaxone (12.5%), Inj. piperacillin tazobactum (9.82%), T. amoxicillin clavulanate (9.82%), Inj. Cefoperazone sulbactum (7.14%). Various classes of antibiotics were utilized to patients with renal impairment. The most widely prescribed were Inj. Meropenem, Inj. Ceftriaxone, T. Amoxicillin clavulanate and Inj. Piperacillin Tazobactum. Awareness raising and monitoring system for various infectious disease and antibiotics prescribed is critical to improve the quality of care in patients with renal impairment.
A. R. Shabaraya, Arkaydius Jyndiang*, Viresh K. Chandur, Assessing And Identifying The Most Commonly Occuring Infections And Antibiotics Prescribed In Renal Impairment Patients In A Tertiary Care Hospital: A Retrospective Study, Int. J. in Pharm. Sci., 2023, Vol 1, Issue 11, 451-457. https://doi.org/10.5281/zenodo.10204125